IBDEI0A7 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4743,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4743,1,2,0)
 ;;=2^682.2
 ;;^UTILITY(U,$J,358.3,4743,1,5,0)
 ;;=5^Cellulitis trunk
 ;;^UTILITY(U,$J,358.3,4743,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,4744,0)
 ;;=682.9^^39^361^1
 ;;^UTILITY(U,$J,358.3,4744,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4744,1,2,0)
 ;;=2^682.9
 ;;^UTILITY(U,$J,358.3,4744,1,5,0)
 ;;=5^Cellulitis NOS
 ;;^UTILITY(U,$J,358.3,4744,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,4745,0)
 ;;=691.8^^39^362^4
 ;;^UTILITY(U,$J,358.3,4745,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4745,1,2,0)
 ;;=2^691.8
 ;;^UTILITY(U,$J,358.3,4745,1,5,0)
 ;;=5^Atopic Dermatitis
 ;;^UTILITY(U,$J,358.3,4745,2)
 ;;=^87342
 ;;^UTILITY(U,$J,358.3,4746,0)
 ;;=692.70^^39^362^1
 ;;^UTILITY(U,$J,358.3,4746,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4746,1,2,0)
 ;;=2^692.70
 ;;^UTILITY(U,$J,358.3,4746,1,5,0)
 ;;=5^Actinic Dermatitis
 ;;^UTILITY(U,$J,358.3,4746,2)
 ;;=^271910
 ;;^UTILITY(U,$J,358.3,4747,0)
 ;;=692.9^^39^362^3
 ;;^UTILITY(U,$J,358.3,4747,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4747,1,2,0)
 ;;=2^692.9
 ;;^UTILITY(U,$J,358.3,4747,1,5,0)
 ;;=5^Allergic Dermatitis
 ;;^UTILITY(U,$J,358.3,4747,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,4748,0)
 ;;=373.31^^39^362^10
 ;;^UTILITY(U,$J,358.3,4748,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4748,1,2,0)
 ;;=2^373.31
 ;;^UTILITY(U,$J,358.3,4748,1,5,0)
 ;;=5^Eyelid Dermatitis
 ;;^UTILITY(U,$J,358.3,4748,2)
 ;;=Eyelid Dermatitis^269060
 ;;^UTILITY(U,$J,358.3,4749,0)
 ;;=694.0^^39^362^12
 ;;^UTILITY(U,$J,358.3,4749,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4749,1,2,0)
 ;;=2^694.0
 ;;^UTILITY(U,$J,358.3,4749,1,5,0)
 ;;=5^Herpetiformis Dermatitis
 ;;^UTILITY(U,$J,358.3,4749,2)
 ;;=^33052
 ;;^UTILITY(U,$J,358.3,4750,0)
 ;;=698.4^^39^362^15
 ;;^UTILITY(U,$J,358.3,4750,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4750,1,2,0)
 ;;=2^698.4
 ;;^UTILITY(U,$J,358.3,4750,1,5,0)
 ;;=5^Psychogenic Dermatitis
 ;;^UTILITY(U,$J,358.3,4750,2)
 ;;=Psychogenic Dermatitis^186786
 ;;^UTILITY(U,$J,358.3,4751,0)
 ;;=698.3^^39^362^13
 ;;^UTILITY(U,$J,358.3,4751,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4751,1,2,0)
 ;;=2^698.3
 ;;^UTILITY(U,$J,358.3,4751,1,5,0)
 ;;=5^Neuro Dermatitis
 ;;^UTILITY(U,$J,358.3,4751,2)
 ;;=^70705
 ;;^UTILITY(U,$J,358.3,4752,0)
 ;;=695.3^^39^362^16
 ;;^UTILITY(U,$J,358.3,4752,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4752,1,2,0)
 ;;=2^695.3
 ;;^UTILITY(U,$J,358.3,4752,1,5,0)
 ;;=5^Rosacea, Keratitis
 ;;^UTILITY(U,$J,358.3,4752,2)
 ;;=^107114^370.49
 ;;^UTILITY(U,$J,358.3,4753,0)
 ;;=690.10^^39^362^17
 ;;^UTILITY(U,$J,358.3,4753,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4753,1,2,0)
 ;;=2^690.10
 ;;^UTILITY(U,$J,358.3,4753,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,4753,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,4754,0)
 ;;=692.81^^39^362^6
 ;;^UTILITY(U,$J,358.3,4754,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4754,1,2,0)
 ;;=2^692.81
 ;;^UTILITY(U,$J,358.3,4754,1,5,0)
 ;;=5^Deodorant Dermatitis
 ;;^UTILITY(U,$J,358.3,4754,2)
 ;;=^271911
 ;;^UTILITY(U,$J,358.3,4755,0)
 ;;=693.0^^39^362^9
 ;;^UTILITY(U,$J,358.3,4755,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4755,1,2,0)
 ;;=2^693.0
 ;;^UTILITY(U,$J,358.3,4755,1,5,0)
 ;;=5^Drug Dermatitis(Internal, Taken Appropriately)
 ;;^UTILITY(U,$J,358.3,4755,2)
 ;;=^33042
 ;;^UTILITY(U,$J,358.3,4756,0)
 ;;=692.3^^39^362^8
 ;;^UTILITY(U,$J,358.3,4756,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4756,1,2,0)
 ;;=2^692.3
 ;;^UTILITY(U,$J,358.3,4756,1,5,0)
 ;;=5^Drug Dermatitis(External)
 ;;^UTILITY(U,$J,358.3,4756,2)
 ;;=^271905
 ;;^UTILITY(U,$J,358.3,4757,0)
 ;;=693.1^^39^362^11
